What is the Share Price of Piramal Pharma Ltd?

Piramal Pharma Ltd share price is ₹219.04 As on 14 May, 2025|17:25

Home
>
Stocks
>
Piramal Pharma Ltd

Piramal Pharma Ltd Share Price

Q: What is the Market Cap of Piramal Pharma Ltd?

The Market Cap of Piramal Pharma Ltd is ₹28,106 As on 14 May, 2025|17:25

Q: What is PE Ratio of Piramal Pharma Ltd?

The P/E ratio of Piramal Pharma Ltd is 543 As on 14 May, 2025|17:25

Q: What is PB Ratio of Piramal Pharma Ltd?

The PB ratio of Piramal Pharma Ltd is 3.68 As on 14 May, 2025|17:25

₹ 219.04 +4.20 (1.95%)
Updated on 14-05-2025 4:41 PM

Stock Rating

Pros 2

Cons 6

Piramal Pharma Ltd Price Performance

Day's Low
₹214.22

Day's High
₹220

₹ 219.04

52-w low
₹136.1

52-w high
₹307.9

219.04

Day's open
₹215.87
Previous close
₹214.839996
VWAP
₹217.4
Lower price band
₹171.87
Upper price band
₹257.8

Today's Market Action

The last traded share price of Piramal Pharma Ltd was 219.04 up by 1.95% on the NSE. Its last traded stock price on BSE was 219.00 up by 1.91%. The total volume of shares on NSE and BSE combined was 3,730,333 shares. Its total combined turnover was Rs 81.10 crores.

Piramal Pharma Ltd Medium and Long Term Market Action

Piramal Pharma Ltd hit a 52-week high of 307.9 on 06-11-2024 and a 52-week low of 136.1 on 04-06-2024. The stock price of Piramal Pharma Ltd is down by 0% over the last one month. It is up by 42.79% over the last one year. Don't forget to check the full stock price history in the table below.

Piramal Pharma Ltd Fundamentals

Market Cap (Cr): 28106
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Piramal Pharma Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Piramal Pharma Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Piramal Pharma Ltd

Data not available.

Piramal Pharma Ltd FAQ's

What is Share Price of Piramal Pharma Ltd?

What is the Market Cap of Piramal Pharma Ltd?

What is PE Ratio of Piramal Pharma Ltd?

What is PB Ratio of Piramal Pharma Ltd?

What is the CAGR of Piramal Pharma Ltd?

How to Buy Piramal Pharma Ltd Share?

Can I buy Piramal Pharma Ltd from Samco?

How do I buy Piramal Pharma Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Momentum Strength
The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
Great Cash Conversion of Profits
The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 73.46% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Low Interest Coverage
The company has a very low Interest coverage ratio of 2.67 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.86. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 201 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(14/05/2025)

102

Margin of Safety Index: High

0% People are bullish about Piramal Pharma Ltd

0 % People are bearish about Piramal Pharma Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %